COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Antepartum Etonogestrel Contraceptive Implant Insertion at Term

Phase 1

Withdrawn

Conditions: Contraception

Interventions: Drug: Etonogestrel 68Mg Implant

First Posted Date: 2018-09-04

Last Posted Date: 2019-04-17

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT03656289

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Bikes For Life: Measuring the Effects of a Bicycle Distribution Program on Pediatric Obesity

Not Applicable

Completed

Conditions: Obesity, Childhood

Interventions: Other: Bicycle intervention

First Posted Date: 2018-09-04

Last Posted Date: 2018-09-04

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 525

Registration Number: NCT03656991

Nutritional Formulation for Angelman Syndrome

Not Applicable

Completed

Conditions: Angelman Syndrome

Interventions: Dietary Supplement: Placebo Formulation
Dietary Supplement: Nutritional Formulation Containing Exogenous Ketones

First Posted Date: 2018-08-23

Last Posted Date: 2020-08-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 15

Registration Number: NCT03644693

Locations: 🇺🇸
Children's Hopsital Colorado, Aurora, Colorado, United States

Radiotherapy with Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Phase 1

Active, not recruiting

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Durvalumab
Radiation: Stereotactic Body Radiation Therapy (SBRT)
Procedure: Standard of Care Therapy

First Posted Date: 2018-08-17

Last Posted Date: 2025-02-27

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 21

Registration Number: NCT03635164

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Memorial Hospital Central, Colorado Springs, Colorado, United States
🇺🇸
Poudre Valley Hospital, Fort Collins, Colorado, United States

Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions

Conditions: Chronic Pancreatitis

First Posted Date: 2018-08-15

Last Posted Date: 2024-05-22

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 500

Registration Number: NCT03632616

Locations: 🇺🇸
University of Colorado Anschutz Medical Center, Aurora, Colorado, United States
🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy

Active, not recruiting

Conditions: Hirschsprung's Disease
Spastic Esophageal Disorders
Zenker's Diverticulum
Esophageal Obstruction
Gastroparesis
Gastrointestinal Neoplasia

First Posted Date: 2018-08-13

Last Posted Date: 2024-05-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 250

Registration Number: NCT03626350

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition

Recruiting

Conditions: Endoscopic Suturing
Endoscopic Clipping
Transoral Outlet Reduction
Bariatric Endoscopy
Endoscopic Tissue Apposition
Endoscopic Sleeve Gastroplasty

First Posted Date: 2018-08-10

Last Posted Date: 2024-05-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 500

Registration Number: NCT03626194

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

Phase 1

Recruiting

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: MAS-1 adjuvanted Insulin B-chain

First Posted Date: 2018-08-09

Last Posted Date: 2024-09-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 28

Registration Number: NCT03624062

Locations: 🇺🇸
University of Colorado, Denver, Aurora, Colorado, United States

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

Phase 1

Active, not recruiting

Conditions: Diabetes Complications
Weight Loss
Diabetic Nephropathies
Type 2 Diabetes Mellitus
Obesity
Bariatric Surgery Candidate
Nephropathy
Diabetic Kidney Disease
Diabetes Mellitus, Type 2
Diabetes Mellitus

Interventions: Drug: Aminohippurate Sodium Inj 20%
Drug: Iohexol Inj 300 mg/mL
Procedure: Vertical Sleeve Gastrectomy
Procedure: Renal Biopsy

First Posted Date: 2018-08-08

Last Posted Date: 2024-04-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 30

Registration Number: NCT03620773

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

Phase 1

Completed

Conditions: Diabetic Nephropathies
Diabetes Mellitus Complication
Autoimmune Diabetes
Juvenile Diabetes
Diabetes Mellitus, Type 1
Nephropathy
Type 1 Diabetes Mellitus

Interventions: Drug: Aminohippurate Sodium Inj 20%
Drug: Iohexol Inj 300 mg/mL

First Posted Date: 2018-08-07

Last Posted Date: 2022-04-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 50

Registration Number: NCT03618420

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy